Omnicell (OMCL) delivers strong second quarter financial results Results exceed previously issued second quarter 2025 guidance for revenues, non-GAAP EBITDA and non-GAAP EPS Raises full year 2025 ...

The Omnicell Inc. posted revenue of $290.6 million in the period. For the current quarter ending in September, Omnicell expects its per-share earnings to range from 30 cents to 37 cents.

Omnicell expects full-year earnings in the range of $1.40 to $1.65 per share, with revenue ranging from $1.13 billion to $1.16 billion.

FORT WORTH, Texas - Omnicell, Inc. (NASDAQ:OMCL), a $1.35 billion market cap healthcare technology company known for its pharmacy and nursing care solutions, has introduced a new line of products ...

The Omnicell team stands in the company’s new innovation lab in South Austin Wednesday, May 7, 2025. Omnicell, a technology company, manufactures automated systems for medication management. The ...

Omnicell today reiterates its first quarter and full year 2025 guidance provided with the Company’s previously issued fiscal year and fourth quarter 2024 earnings release on February 6, 2025.

FORT WORTH, Texas, December 09, 2024--Omnicell Announces OmniSphere; Next-generation, cloud native, software workflow engine will integrate Omnicell solutions across care settings ...

Omnicell assumes no obligation to update any such statements publicly, or to update the reasons actual results could differ materially from those expressed or implied in any forward-looking statements ...

Omnicell has made several changes to its leadership structure. The company said the changes are designed to create a more streamlined organization with a continued focus on operational excellence ...